Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (Q43843458)
Jump to navigation
Jump to search
scientific article published in January 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma |
scientific article published in January 2002 |
Statements
1 reference
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (English)
1 reference
Lynn Feun
1 reference
Peter Naredi
1 reference
Frank Meyskens
1 reference
Sanjiv S Agarwala
1 reference
John Glaspy
1 reference
Steven J O'Day
1 reference
Malcolm Mitchell
1 reference
John Gutheil
1 reference
Eric Whitman
1 reference
Rene Gonzalez
1 reference
Evan Hersh
1 reference
Robert Belt
1 reference
Kristoffer Hellstrand
1 reference
Diana Wood
1 reference
John M Kirkwood
1 reference
Kurt R Gehlsen
1 reference
1 January 2002
1 reference
1 reference
Identifiers
1 reference